Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia

Published:2017-09-27 Issue:4 Volume:32 Page:855-864
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Fujita S,Honma D,Adachi N,Araki K,Takamatsu E,Katsumoto T,Yamagata K,Akashi K,Aoyama K,Iwama A,Kitabayashi I

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017300.pdf

Reference42 articles.

1. Kreso A, Dick JE . Evolution of the cancer stem cell model. Cell Stem Cell 2014; 14: 275–291.

2. Szer J . The prevalent predicament of relapsed acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2012; 2012: 43–48.

3. Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 2007; 25: 1315–1321.

4. Gentles AJ, Plevritis SK, Majeti R, Alizadeh AA . Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 2012; 304: 2706–2715.

5. Takeishi S, Matsumoto A, Onoyama I, Naka K, Hirao A, Nakayama KI . Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. Cancer Cell [Internet].; 2013; 23: 347–361.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tricking the trickster: precision medicine approaches to counteract leukemia immune escape after transplant;Blood;2024-06-27

2. Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers;Cancer Research;2024-06-04

3. Recurrent spinal atypical teratoid/rhabdoid tumor with pulmonary metastasis;Cancer Reports;2024-01-13

4. Differentiation of Acute Leukemia Cells Including Cells with MLL-AF4 Rearrangements Induced by Jiyuan Oridonin A;Recent Patents on Anti-Cancer Drug Discovery;2024-01-09

5. FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia;Leukemia;2024-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3